Tag: appos-seattle-2026

  • APPOS Seattle 2026

    APPOS Seattle 2026 (Advanced Practice Providers Oncology Summit) will take place May 15-16, 2026, at The Hilton Bellevue Hotel. The two-day continuing education conference is organized by Horizon CME.

    The summit is designed for advanced practice providers, including nurse practitioners, physician assistants, pharmacists and nurses, and aims to equip attendees with the latest evidence-based strategies to improve cancer patient care and outcomes.

    Planned sessions cover a range of topics, including the rising incidence of early-onset colorectal cancer, new treatments for non-small cell lung cancer, managing nutritional impact symptoms, and an APP-led panel on surveillance and survivorship clinics.

  • APPOS Seattle 2026

    APPOS Seattle 2026 (Advanced Practice Providers Oncology Summit) will be held May 15–16, 2026, at The Hilton Bellevue Hotel.

    Organized by Horizon CME, the two-day continuing education conference is designed for advanced practice providers — including nurse practitioners, physician assistants, pharmacists and nurses — and aims to deliver the latest evidence-based strategies to improve cancer patient care and outcomes.

    Agenda highlights include the rising incidence of early-onset colorectal cancer, emerging treatments for non-small cell lung cancer, management of nutritional impact symptoms, and an APP-led panel on surveillance and survivorship clinics.

  • APPOS Seattle 2026

    APPOS Seattle 2026, the Advanced Practice Providers Oncology Summit, will be held May 15–16, 2026, at The Hilton Bellevue in Bellevue, Washington.

    Organized by Horizon CME, the two-day continuing education conference is designed for advanced practice providers, including nurse practitioners, physician assistants, pharmacists and nurses, and will present the latest evidence-based strategies to improve cancer patient care and outcomes.

    The agenda covers a range of topics, including the rising incidence of early-onset colorectal cancer, new treatments for non-small cell lung cancer, management of nutritional impact symptoms, and an APP-led panel on surveillance and survivorship clinics.